drugset / Trial / NCT00061776

NGX-4010 for the Treatment of Postherpetic Neuralgia

NCT00061776

Phase 2/3 Completed 300 enrolled NeurogesX
RandomizedDouble-blindTreatment

Summary

The purpose of the study is determine if an investigational drug, NGX-4010 (high-concentration capsaicin dermal patches) is effective in treating pain associated with post-herpetic neuralgia (PHN).

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule Topical

Indications